MSB 3.33% $1.40 mesoblast limited

Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-97

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,002 Posts.
    lightbulb Created with Sketch. 315
    Great news, this underpins MSB. Now this is public knowledge it can be freely discussed. I anticipate a deal, one with enough upfront to deal with p4’s (yes plural) and fund operations for the next 12 months, where further milestones kick in. I think Novartis is odds on favourite. Such a partner would assist is FDA discussions. Anybody who think we’re not on the minds of big pharma, you’re dreaming. Well done everyone.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.